See Cancer In Real Time

CYTALUX® is the latest advancement in Intraoperative Molecular Imaging that illuminates cancer in real time.

CYTALUX is the only FDA approved optical imaging agent indicated as an adjunct for intraoperative identification of malignant lesions in adult patients with ovarian cancer and malignant and non-malignant pulmonary lesions in adult patients with known or suspected cancer in the lung.

In clinical trials, CYTALUX detected additional ovarian and lung cancer
that wouldn’t have been detected otherwise.

* Women highly suspicious for or with confirmed ovarian cancer who underwent both normal and fluorescent light evaluation (Intent-to-Image set); N=134, 95% CI [19.6, 35.2]

New: Stryker 1788 Platform is now cleared for use with CYTALUX

Speak with a representative
about CYTALUX and how to bring this technology to your OR.